Mr. Johnston is currently the head of Robert Johnston Associates. Mr. Johnston was President of Johnston Associates, a venture capital firm which he founded in 1968 to provide seed capital for start-ups emerging in the biotechnology and healthcare fields. Mr. Johnston is the executive chairman of Pharmos Corporation, which acquired Vela Pharmaceuticals, Inc. He was acting CEO at ExSAR from July 2001 until the appointment of Dr. Almassian as CEO and President in August 2005. He has founded numerous public companies including Sepracor, Cytogen, I-STAT, Genex and Envirogen, and was instrumental in the early formation of many private companies such as Sonomed, Immunicon, PharmaStem (formerly Biocyte), Praelux and Targent. Mr. Johnston served as CEO of Cytogen from July 1988 to April 1989 and as CEO of Praelux (formerly SEQ) from November 1997 to January 1999. Additionally, he is a member of the Advisory Council of the Department of Molecular Biology at Princeton University, and the Executive Committee of the Friends of the Institute for Advanced Study in Princeton, New Jersey. Mr. Johnston received his B.A. from Princeton University and his M.B.A. from New York University.

Company Profile (History) | Senior Management Team | Board of Directors | Scientific Advisory Board
Robert F. Johnston - Chairman of the Board | Charles R. Cantor, Ph.D. | Myra Williams, Ph.D. | Arnold Levine, Ph.D. | Bijan Almassian, Ph.D.